Home > PS Ratio > BALAXI PHARMACEUTICALS

BALAXI PHARMACEUTICALS
PS (Price/Sales) Ratio

The Current P/S Ratio of BALAXI PHARMACEUTICALS is 2.72.

Share Price ₹648.6May 17,2024
Market Cap ₹713.5 Cr
Sales-TTM₹262.1 CrTTM-Consolidated Results
Price/Sales2.72xCalculated as Market Cap/Sales
Explore Stock Analytics
COMMUNITY POLL
for BALAXI PHARMACEUTICALS
Please provide your vote to see the results
BALAXI PHARMACEUTICALS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best 1M Momentum Small Cap Stocks

Definition & Calculation of PS (Price/Sales) ratio of BALAXI PHARMACEUTICALS

Price-to-Sales ratio, P/S Multiple, or P/S Ratio is an important valuation multiple that is defined as:

P/S = Market Capitalization / Sales

or, using per-share numbers:

P/S = Stock Price / Sales Per Share

Applying the above formula, P/S ratio of BALAXI PHARMACEUTICALS is calculated as :

Current Market Cap [ ₹713.5 Cr] as on May 17,2024

(/) Sales [ ₹262.1 Cr] based on TTM-Consolidated Results

(=) P/S Ratio [ 2.72x ]

P/S Ratio indicates 'the multiple of sales' investors are willing to pay to own one share of the company.

Thus, for BALAXI PHARMACEUTICALS , the investors are currently willing to pay '2.72 times sales' to own 1 share of the company.

PS Multiples are one of the most widely used valuation multiple in the industry.

P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.

You may also explore Price to Earnings ratio or Price to Book ratio of BALAXI PHARMACEUTICALS !

The chart below summarizes the trend in P/S Ratio of BALAXI PHARMACEUTICALS over the last five years.

Historical PS (Price/Sales) ratio chart of BALAXI PHARMACEUTICALS


PS Ratio Performance Analysis for BALAXI PHARMACEUTICALS

- BALAXI PHARMACEUTICALS 's latest p/e ratio is 2.72x.

- BALAXI PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2023 to Mar2019 averaged 1.52x.

- BALAXI PHARMACEUTICALS 's operated at median p/e ratio of 1.6x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, BALAXI PHARMACEUTICALS 's p/e ratio peaked in Mar2021 at 2.27x.

- BALAXI PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2019 of 0.85x.


How does BALAXI PHARMACEUTICALS 's P/S Ratio benchmark against top 10 peers in Trading Industry?

Peer Comparison (Trading Industry)Sales (Cr)PS RatioMarket Cap (Cr)
BALAXI PHARMACEUTICALS 262.12.72713.5
ADANI ENTERPRISES LTD105,472.03.31348,869.0
REDINGTON LTD89,345.70.1816,491.5
HONASA CONSUMER LTD1,777.07.5313,381.6
MMTC LTD712.915.7411,224.5
MSTC LTD748.38.936,683.8
LLOYDS ENTERPRISES LTD958.44.384,194.2
VERITAS (INDIA) LTD3,419.01.063,609.0
NOVARTIS INDIA LTD335.18.122,721.5
OPTIEMUS INFRACOM LTD1,378.11.742,397.6
MISHTANN FOODS LTD322.46.021,941.8

Trading Industry Benchmark (Top 10) PS Analysis vs BALAXI PHARMACEUTICALS 's P/S Ratio

Top 10 Industry PeersPS Ratio
Min industry PS 0.18x
Max industry PS 15.74x
Median industry PS 4.38x
Average industry PS 5.43x



You may also like the below Video Courses